One of the long-term success stories in U.S. manufacturing is that of Ingersoll Rand, with history dating back to the 1870s as the Industrial Revolution gained great momentum in North America.
The company’s products were needed by other industrial revolution companies (such as compressors), by mining companies (rock drills), and in various elements (locks and more) of the b-to-b market. When the Panama Canal was being built by the U.S., Ingersoll Rand drills were on the job.
There are a number of “best of” lists that corporate managers and investment professionals scour to see what companies are judged to be doing well (by the list makers)…whether they be industry peers & competitors, or possible acquisitions or partners, and for investors, whether the listed firms might be the right choices for investment portfolios.
BALTIMORE, July 17, 2019 /3BL Media/ - Pinkaloo, a personal charitable giving management software that helps companies build stronger relationships with their customers and employees through philanthropy, is pleased to announce it has launched a charitable giving pilot, “Give for Good,” with Eastern Bank during the inaugural MassChallenge FinTech (MCFT) program.
When a cause needs to process a paper donation check, it creates costly administrative work. Non-profits must deposit checks individually and issue manual tax receipts to each donor. Checks also get lost in the mail or worse, sit uncashed!
Electronic payments cut down on manual administration time and reduce costs. Unlike other software providers in this space, Benevity sends the majority (88% in 2018!) of payments processed through our platform electronically, with funds arriving within 30 days.
GRI Chief Executive testifies to US House Committee on strengthening ESG legislation
July 10, 2019 /3BL Media/ - GRI’s Chief Executive, Tim Mohin, testified today (10 July) before the US House Committee on Financial Services, which is considering new corporate reporting requirements for Environmental, Social and Governance (ESG) information.
Pfizer is committed to ensuring that the manufacturing, use and disposal of our products, including antibiotics, does not adversely affect human health or the environment. Core to this commitment is taking action to assess and reduce, as needed, the risk of antibiotics in wastewater from Pfizer and supplier manufacturing facilities